Hypersoft Advanced
Device Neurological Product
PDI 00811425027646
General payments
$143,751
Research payments
$2,515,413
Through program year 2025, $143,751 in general payments and $2,515,413 in research payments were reported against Hypersoft Advanced (Neurological Product).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $66,850 | 9 |
| 2025 | Research | $1,004,668 | 172 |
| 2024 | General | $76,514 | 13 |
| 2024 | Research | $1,294,287 | 220 |
| 2023 | General | $280 | 7 |
| 2023 | Research | $216,458 | 33 |
| 2022 | General | $108 | 5 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
34 general · 425 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.